Very well put John. It really doesn't matter. In all honesty, we all think FDA will be delayed due to covid, but it really depends on the TYPE of application. Do you really think they are fancying piling up applications? If anything they'd like to speed up some "easy" ones to offload the workload a little. Drugs/medicine are the really nitty-gritty ones. Devices or software and alikes dont require as much digging and might be processed quicker (proven with examples too). As correctly mentioned, commercialisation of Ilumen is just as huge of a milestone as FDA, so say end of September we hear that, and next month we hear FDA news. Given the approval, it's a back to back banger news that will seriously re-rate this company. Many might see me as too optimistic but if we get those 2 news, plus positive outlook for CE, we might wave a hello to 10c. Huge potential. GLTAH
MEB Price at posting:
1.1¢ Sentiment: Buy Disclosure: Held
